Clinical Trial Update: The Safety and Effectiveness of Taneasy and Actein in COPD Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and effectiveness of Taneasy and Actein in COPD patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Actein
• Taneasy

Snippet

Sponsor: Bun Yao Biotechnology Co., Ltd | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | Phase 4 | Status: COMPLETED